Sandoz Expects Imminent US Pegfilgrastim Action

Seven Months Have Passed Since Refiling With FDA

 
• By Aidan Fry
Approved_Stamp
Sandoz is eagerly awaiting FDA clearance for its pegfilgrastim biosimilar candidate • Source: Shutterstock

More from Biosimilars

More from Products